What is the starting dose of venlafaxine (Effexor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Venlafaxine (Effexor)

The recommended starting dose for venlafaxine is 75 mg/day, administered in two or three divided doses, taken with food. 1

Dosing Guidelines

  • The FDA-approved initial treatment dose is 75 mg/day, divided into two or three doses, and should be taken with food 1
  • Depending on tolerability and clinical need, the dose may be increased to 150 mg/day and further to 225 mg/day if needed 1
  • When increasing the dose, increments of up to 75 mg/day should be made at intervals of no less than 4 days 1
  • For neuropathic pain management, the minimum effective dose is also 75 mg/day, with an efficacious range typically between 150-225 mg/day 2

Special Populations

  • For patients with mild to moderate hepatic impairment, the total daily dose should be reduced by 50% 1
  • For patients with mild to moderate renal impairment (GFR=10 to 70 mL/min), the total daily dose should be reduced by 25% 1
  • For patients undergoing hemodialysis, the total daily dose should be reduced by 50% 1
  • No dose adjustment is recommended for elderly patients based on age alone, though caution should be exercised when increasing the dose 1

Clinical Efficacy Considerations

  • Clinical studies have established 75 mg/day as the minimum effective dose for depression 3
  • A therapeutic response may be evident as early as week 2 of treatment with doses of 75 to 225 mg/day 4
  • For more severely depressed inpatients, higher doses (mean of 350 mg/day, up to maximum 375 mg/day) may be required 1, 5
  • When used for neuropathic pain, typically 2-4 weeks are required to titrate to an efficacious dosage 2

Safety Considerations

  • The most common adverse effects include nausea (which typically resolves within 1-3 weeks), somnolence, insomnia, and dizziness 5
  • Blood pressure monitoring is important, particularly at higher doses, as venlafaxine can cause modest increases in blood pressure 2, 5
  • At doses ≤200 mg/day, 3-5% of patients experience blood pressure elevation; this increases to 7% at 201-300 mg/day and 13% at >300 mg/day 5
  • Abrupt discontinuation should be avoided; the medication should be tapered when discontinuing to prevent withdrawal symptoms 2

Formulation Considerations

  • Venlafaxine is available in both immediate-release (requiring multiple daily doses) and extended-release formulations (once-daily dosing) 4
  • Extended-release formulation has been shown to be more effective than immediate-release at equivalent doses (75-150 mg/day) in some studies 4

This dosing information provides a clear starting point of 75 mg/day for most patients, with appropriate adjustments based on clinical response, tolerability, and patient-specific factors such as hepatic or renal impairment.

References

Guideline

Dose-Response Relationship and Safety Considerations for Venlafaxine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacologic profile and efficacy of venlafaxine.

International clinical psychopharmacology, 1995

Research

The role of venlafaxine in rational antidepressant therapy.

The Journal of clinical psychiatry, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.